Skip to main content
Smart Investors Daily
RV

NASDAQ · RVLP

RVL Pharmaceuticals plc

Healthcare · Biotechnology

$0.03

Down-$0.01 (-32.05%)

Updated Sep 10, 2026, 6:05 PM

SID Score

Composite research score

Smart Money

Institutional and insider signal

Market cap
3.14M
P/E ratio
-0.05
Dividend yield
0.00%
52-week range
— – —
Volume
63.96M
Avg. volume
24.42M

Price performance

RVLP price history

1M range · 0 trading sessions · Daily adjusted prices

RVLP does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest RVLP news

The latest Smart Investors Daily articles mentioning RVLP.

RVLP research

Overview

Company profile and research snapshot.

Company profile

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
RVLP recent ratings
DateFirmRatingTarget
Aug 21, 2023HC Wainwright & Co.Buy
May 1, 2023BarclaysOverweight
Mar 21, 2023HC Wainwright & Co.Buy
Oct 25, 2022BarclaysOverweight
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Oct 20, 2023

Why Adial Pharmaceuticals Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares jumped 60.2% to $0.5101 after jumping 34% on Thursday. Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) climbed 58.7% to $2.46. Lipella Pharmaceuticals announced FDA clearance of IND for LP-310 for oral lichen planus. Catalyst Biosciences, Inc. (NASDAQ: CBIO) jumped 44% to $0.5780. MMTec, Inc. (NASDAQ: MTC) gained 37.6% to $2.84 after jumping 51% on Thursday. MMTEC is scheduled to hold its 2023 annual meeting of shareholders on Nov. 10, 2023. Nouveau Monde Graphite Inc. (NYSE: NMG) surged 28% to $2.60 Aravive, Inc. (NASDAQ: ARAV) shares climbed 26.3% to $0.1780 after falling 15% on Thursday. HUB Cyber Security Ltd. (NASDAQ: HUBC) shares jumped 22.7% to $0.6994 after jumping 25% on Thursday. HUB Cyber Security recently reported the strategic appointment of Mr. Noah Hershcoviz as Chief Strategy Officer and a member of the Company’s Board of Directors. Urgent.ly Inc. (NASDAQ: ULY) shares gained 21% to $6.66 after falling around 52% on Thursday. Urgent.ly announced the closing of its acquisition of Otonomo Technologies Ltd. FLJ Group Limited (NASDAQ: FLJ) surged 17.5% to $ 0.2574. Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) gained 17.4% to $0.3199. Versus Systems Inc. (NASDAQ: VS) climbed 16.8% to $0.2150. American Well Corporation (NYSE: AMWL) shares rose 13.9% to $1.0750. American Well and Leidos Holdings have recently won a next-generation contract to provide a hybrid care technology platform designed to power the "Digital First" transformation of the U.S. Military Health System (MHS). Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR) shares climbed 12.1% to $1.11 after falling 12% on Thursday. Knight-Swift Transportation Holdings Inc. (NYSE: KNX) shares gained 11.1% to $50.95 after the company reported better-than-expected third-quarter financial results. Intelligent Living Application Group ...

GlobeNewswire Inc. · Aug 23, 2023

RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment Conference

BRIDGEWATER, N.J., Aug. 23, 2023 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company, today announced that Brian Markison, Chief Executive Officer, will participate in a fireside chat and host 1x1 investor meetings at the H.C. Wainwright 25th Annual Global Investment Conference in New York City as follows:

Benzinga · Aug 16, 2023

Crude Oil Falls Sharply; RVL Pharmaceuticals Shares Plummet

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 50 points on Wednesday. The Dow traded up 0.07% to 34,970.67 while the NASDAQ fell 0.31% to 13,588.34. The S&P 500, also fell, dropping, 0.03% to 4,436.32. Check This Out: Verizon, S&P Global And 2 Other Stocks Insiders Are Selling   Leading and Lagging Sectors Utilities shares rose by 0.9% on Wednesday. In trading on Wednesday, communication services shares fell by 0.6%.   Top Headline U.S. crude oil inventories declined by 5.96 million barrels in the week to Aug. 11, 2023, compared to market expectations for a 2.32 million barrel decline, the EIA said.   Equities Trading UP Novo Integrated Sciences, Inc. (NASDAQ: NVOS) shares shot up 72% to $0.20. Novo Integrated Sciences issued an update on certain current actions and events. The company recently reported a year-over-year increase in third-quarter EPS results. Shares of DLocal Limited (NASDAQ: DLO) got a boost, shooting 34% to $20.72 after the company reported better-than-expected financial results for its second quarter and reaffirmed FY23 revenue guidance. Tivic Health Systems, Inc. (NASDAQ: TIVC) shares were also up, gaining 65% to $0.0615 after the company announced its funded study started enrollment for its non-invasive bioelectronic device approach to vagus nerve stimulation.   Equities Trading DOWN RVL Pharmaceuticals plc (NASDAQ: RVLP) shares dropped 45% to ...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.